Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT04799431
What this trial is testing

Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Cancer MetastaticColorectal Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT05039177
What this trial is testing

ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic Ductal Adenocarcinoma
Erasca, Inc. 101
Not applicableStudy completedNCT00564694
What this trial is testing

Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 350
Not applicableStudy completedNCT04349384
What this trial is testing

Audit of Surgery for Colorectal Cancer

Who this might be right for
Rectal AdenocarcinomaColon Adenocarcinoma
Institut National d'Oncologie, Morocco 136
Large-scale testing (Phase 3)Study completedNCT00316914
What this trial is testing

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery

Who this might be right for
Colorectal CancerNeurotoxicity
Alliance for Clinical Trials in Oncology 104
Testing effectiveness (Phase 2)Ended earlyNCT00004193
What this trial is testing

ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Alabama at Birmingham 25
Not applicableUnknownNCT05422547
What this trial is testing

Role of Immunoscore® in Stage II-III Colorectal Cancer

Who this might be right for
Colon Adenocarcinoma
D'Or Institute for Research and Education 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07815834
What this trial is testing

FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)

Who this might be right for
Colon Rectal Cancer AdenocarcinomaPeritoneal (Metastatic) CancerSecond-line Treatment+2 more
Fudan University 198
Testing effectiveness (Phase 2)Ended earlyNCT01479465
What this trial is testing

Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Who this might be right for
Colorectal Cancer
Gilead Sciences 266
Testing effectiveness (Phase 2)Study completedNCT00003834
What this trial is testing

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 44
Testing effectiveness (Phase 2)WithdrawnNCT01176500
What this trial is testing

A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors

Who this might be right for
Colon CancerLung CancerCervical Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT03693846
What this trial is testing

Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum
Abramson Cancer Center at Penn Medicine 11
Testing effectiveness (Phase 2)Ended earlyNCT00625183
What this trial is testing

Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute 5
Testing effectiveness (Phase 2)UnknownNCT00513266
What this trial is testing

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
Centre Hospitalier Universitaire Vaudois 35
Testing effectiveness (Phase 2)Study completedNCT07460596
What this trial is testing

Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea

Who this might be right for
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaColon and Rectal Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00056030
What this trial is testing

Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 73
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT00033306
What this trial is testing

BMS-247550 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Alabama at Birmingham 2
Testing effectiveness (Phase 2)Study completedNCT00597506
What this trial is testing

Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus

Who this might be right for
Colorectal Adenocarcinoma
Herbert Hurwitz 50
Early research (Phase 1)Study completedNCT05784597
What this trial is testing

Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors

Who this might be right for
Breast CancerColorectal CancerOesophageal Cancer+1 more
Philogen S.p.A. 18
Next Page